000254060 000__ 01465cam\a2200361Ia\4500
000254060 001__ 254060
000254060 005__ 20220217104607.0
000254060 008__ 940225s1993\\\\mdua\\\\\\\\\f000\0\eng\d
000254060 0167_ $$a9420792$$2DNLM
000254060 035__ $$a(OCoLC)ocm29872080
000254060 035__ $$a254060
000254060 040__ $$aGPO$$cGPO$$dVYL$$dAGL$$dNLM$$dGPO
000254060 043__ $$an-us---
000254060 049__ $$aISEA
000254060 072_0 $$aX380
000254060 074__ $$a0507-E-01
000254060 0860_ $$aHE 20.3202:C 45/14/993/EXEC.SUM.$$zHE 20.3202:B 62/25/EXEC.SUM.
000254060 090__ $$aRC632.H83$$bS42 1993, Summ.
000254060 24500 $$aSecond report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II) :$$bexecutive summary.
000254060 260__ $$a[Bethesda, Md.?] :$$bNational Cholesterol Education Program, U.S. National Institutes of Health, National Heart, Lung, and Blood Institute,$$c[1993]
000254060 300__ $$a28 p. :$$bill. ;$$c23 cm.
000254060 440_0 $$aNIH publication ;$$vno. 93-3096
000254060 500__ $$aShipping list no.: 94-0042-P.
000254060 500__ $$a"September 1993."
000254060 650_0 $$aBlood cholesterol$$zUnited States.
000254060 650_0 $$aHypercholesteremia$$zUnited States.
000254060 65012 $$aHypercholesterolemia$$xtherapy.
000254060 65022 $$aCoronary Disease$$xprevention & control.
000254060 65022 $$aLipoproteins, LDL Cholesterol$$xadverse effects.
000254060 655_7 $$aPractice Guideline.$$2mesh
000254060 7102_ $$aNational Cholesterol Education Program (U.S.)
000254060 7400_ $$aDetection, evaluation, and treatment of high blood cholesterol in adults.
000254060 85230 $$bdfich$$hHE 20.3202:$$iC 45/14/993/EXEC.SUM.
000254060 909CO $$ooai:library.usi.edu:254060$$pGLOBAL_SET
000254060 980__ $$aBIB
000254060 980__ $$aGOV RESOURCE
000254060 994__ $$aE0$$bISE